Defining hereditary alpha-tryptasemia as a risk/modifying factor for anaphylaxis: are we there yet?

Area of Science:

• Genetics
• Immunology
• Allergy

Background:

• Hereditary α-tryptasemia (HαT) is a common autosomal dominant genetic trait characterized by elevated serum baseline tryptase (SBT) levels.
• Clinical manifestations of HαT range from asymptomatic to severe, recurrent anaphylaxis.
• Proposed mechanisms involve excessive activation of EMR2 and PAR-2 receptors by α/β-tryptase heterotetramers.

Purpose of the Study:

• To review existing evidence and determine if HαT is a hereditary risk or modifying factor for anaphylaxis.
• To investigate the association between HαT and anaphylaxis severity and frequency.

Main Methods:

• Literature review of studies investigating the link between HαT and anaphylaxis.
• Analysis of evidence regarding HαT's role in anaphylaxis in general population and patients with clonal mast cell disorders.

Main Results:

• Increased SBT levels, often seen in HαT, are linked to increased anaphylaxis risk.
• Some studies suggest HαT is associated with higher risk and severity of anaphylaxis, including in patients with clonal mast cell disorders.
• Conflicting results and small sample sizes in existing studies limit definitive conclusions.

Conclusions:

• The role of HαT as a hereditary risk or modifying factor for anaphylaxis requires further investigation.
• Additional large-scale studies are needed to explore the association of HαT with anaphylaxis across different triggers and severity grades.
• Clarifying HαT's impact on anaphylaxis in both the general population and specific patient groups is crucial.